Laurus Labs Ltd Share Price – NSE  / BSE

Pharmaceuticals, Small Cap

Laurus Labs Ltd gained for a third straight session today. The stock is quoting at Rs 1033.9, up 1.81% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.53% on the day, quoting at 25951.35. The Sensex is at 84911.21, up 0.51%. Laurus Labs Ltd has risen around 4.74% in last one month.

Meanwhile, Nifty Pharma index of which Laurus Labs Ltd is a constituent, has risen around 0.3% in last one month and is currently quoting at 22557.6, up 0.27% on the day. The volume in the stock stood at 19.64 lakh shares today, compared to the daily average of 14.12 lakh shares in last one month.

The benchmark December futures contract for the stock is quoting at Rs 1035.7, up 1.65% on the day. Laurus Labs Ltd is up 84.89% in last one year as compared to a 10.02% spurt in NIFTY and a 0.52% spurt in the Nifty Pharma index.

The PE of the stock is 80.25 based on TTM earnings ending September 25.

Powered by Capital Market - Live News

Laurus Labs has allotted 31,683 equity shares under ESOP on 02 December 2025. The total paid up capital of the Company after the above allotment stands at Rs.1,07,97,13,164/-.

Powered by Capital Market - Live News

Laurus Labs Ltd is up for a third straight session in a row. The stock is quoting at Rs 1029.75, up 2.65% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.03% on the day, quoting at 26207.8. The Sensex is at 85741.54, up 0.02%. Laurus Labs Ltd has added around 7.08% in last one month.

Meanwhile, Nifty Pharma index of which Laurus Labs Ltd is a constituent, has added around 2.21% in last one month and is currently quoting at 22863, up 0.28% on the day. The volume in the stock stood at 15.83 lakh shares today, compared to the daily average of 17.42 lakh shares in last one month.

The benchmark December futures contract for the stock is quoting at Rs 1034.6, up 2.29% on the day. Laurus Labs Ltd is up 81.57% in last one year as compared to a 8.61% gain in NIFTY and a 3.08% gain in the Nifty Pharma index.

The PE of the stock is 79.4 based on TTM earnings ending September 25.

Powered by Capital Market - Live News

Net profit of Laurus Labs rose 882.71% to Rs 194.97 crore in the quarter ended September 2025 as against Rs 19.84 crore during the previous quarter ended September 2024. Sales rose 35.12% to Rs 1653.47 crore in the quarter ended September 2025 as against Rs 1223.70 crore during the previous quarter ended September 2024.

Powered by Capital Market - Live News